Order of the National Green Tribunal in the matter of News Item titled "2 killed in blast at illegal cracker unit in Thanjavur appearing in The Hindu dated 19.05.2025". The application is registered suo-motu on the basis of the news item titled 2 killed in blast at illegal cracker unit …
New Delhi In what would come as a shot in the arm for rural healthcare, the government is planning to form a chain of over 8,000 drug retail outlets spread across the length and breadth of the country to take affordable medicine to the hinterlands. The plan is to set …
New Delhi: A thrice-a-week insulin shot instead of the once-a-day shot at present could soon be a reality. Doctors from India, Canada, US and South Africa have jointly tested the most promising new form of long acting insulin, Degludec, needed once every 48 hours, and found it to be as …
Multinational pharmaceutical drug company MSD, the fully owned subsidiary of Merck & Co, on Wednesday launched a diarrhoea-prevention vaccine RotaTeq for infants and children in India. RotaTeq is a pentavalent rotavirus vaccine that helps in preventing rotavirus gastroenteritis, a leading cause of severe and life threatening diarrhoea in young children. …
At the end of November, Pfizer stands to lose a $10-billion-a-year revenue stream when the patent on its blockbuster cholesterol drug Lipitor expires and cheaper generics begin to cut into the company
First-in-human clinical trials represent a critical juncture in the translation of laboratory discoveries. However, because they involve the greatest degree of uncertainty at any point in the drug development process, their initiation is beset by a series of nettlesome ethical questions: has clinical promise been sufficiently demonstrated in animals? Should …
Global drugmakers have started launching generic or low-priced version of popular medicines and have slashed prices of their existing products to increase market share in India, taking on local competitors in their own game. French drugmaker Sanofi Aventis has launched a range of generic drugs, some at half the price …
Mumbai: You will have to pay more for that flu shot, or to ease pain during surgery. Prices of vaccines, anaesthetics and intravenous fluids (IV fluids) are expected to rise with the imposition of an excise levy. Not just that. Ayurvedic, unani, siddha and homeopathic drugs will also cost more …
Vaccine trials in a Madhya Pradesh government hospital are making children sick. Down To Earth finds out that harmful chemicals in high amounts is the culprit. Vaccine trials in a Madhya Pradesh government hospital are making children sick. Culprit: harmful chemicals in high amounts.
Ajay and Pooja Naik lament the day they took their child for a special vaccination programme. Soon after Yathartha’s birth last year, Ajay learned that a government hospital in Indore in Madhya Pradesh was offering vaccines against many diseases, including polio, H1N1 and hepatitis, for free. What he did not …
Armed with a product patent regime and a string of large acquisitions, multinational drug companies are making a strong comeback in India. Ten multinational companies (MNCs)
Lack of transparency in clinical trial conduct, publication bias and selective reporting bias are still important problems in medical research. Through clinical trials registration, it should be possible to take steps towards resolving some of these problems. However, previous evaluations of registered records of clinical trials have shown that registered …
Mumbai: Vaccines are back in favour. After being junked by pharma biggies some years back, now almost every drug major is investing in vaccines by acquiring or building on fresh capacities. The evidence lies in pharma biggie Pfizer acquiring Wyeth and domestic major Shantha Biotech being snapped up by Sanofi …
Gatifloxacin, an antibiotic widely prescribed for throat infection, and Tegaserod, a medicine for chronic constipation, are likely to be banned in India. The sub-committee of the government
New Delhi: The government will no longer allow popular drugs to be sold under the same name if their active ingredients have been changed. Pharmaceutical companies will now have to also change the brand name of the drug. This was decided by the Drug Controller General of India (DCGI), Dr …
After months of prevarication, the European Union has stated publicly that the free trade agreement (FTA) it signs with India will include provisions for data exclusivity because “it is extremely important for research and innovation’’. That’s what European Union ambassador Daniele Smadja told journalists in Delhi on January 21. Smadja’s …
A missing link in the biosimilar regulatory framework of US could delay and wipe off potential earnings worth billions of dollars from the kitty of India
THE India drug regulator has asked pharmaceutical firms to withdraw several medicines sold under the same brand name but used to treat different ailments as it leads to confusion and could harm consumers for taking a wrong medicine. On Monday, the Drug Controller General of India (DCGI), Surinder Singh, asked …
